Looking for a PhD position?
The Faculty of Biology and Medicine, University of Lausanne, Switzerland offers:
PhD fellowships in life Sciences, starting in may 2017
Click here for more information
Looking for a PhD position?
The Faculty of Biology and Medicine, University of Lausanne, Switzerland offers:
PhD fellowships in life Sciences, starting in may 2017
Click here for more information
Introducing Christina Skaar Saghaug. Christina started in September 2016 as a PhD student at K2. She is going to work with genes for antibiotic resistance in the parasite Giardia lamblia, under the guidance of Kurt Hanevik and Nina Langeland. If you wish to say hello, you can find her in the 5th floor of the laboratory building.
We now have created a website for post docs, where information will be posted consecutively. Click here
On behalf of the Ministry of Foreign Affairs, the Mexican Agency for International Development Cooperation (AMEXCID) invites foreign citizens who are interested in studying for a specialization, master’s degree or doctorate, conducting graduate or postdoctoral research, or taking part in an undergraduate or graduate-level academic mobility program, to participate in the 2017 Mexican Government Scholarship Program for International Students.
UiB has signed a new framework agreement for purchases and delivery of flowers in connection with our employee anniversaries, PhD defenses and other markings where the presentation of flowers is part of the even.
The framework agreement was signed with Botanica Flowers AS who might be familiar to most.
The agreement is active, and it created a new directory that you find in the BasWare PM with prices and pictures of the different options.
The agreement can be found here: https://sourcing.amesto.com/Avantra/Customer/Bergen/Modules/Contract/Card/Default.aspx?ContractId=3207&search=blomster
Botanica’s website can be found here: http://www.botanica.no/
We remind you that it is important that we are loyal to the framework agreement when ordering flowers.
It is time for the annual employee appraisal. All employees at K2 have the right to have an annual appraisal with a supervisor at the department. The appraisal is important, primarily for the individual who has the opportunity to take up current issues related to his/her work situation as well as topics such as skills upgrading and career. The supervisor has the opportunity to follow up on the individual’s work and matters relating to it. Hopefully the appraisal will help enhancing the working environment at K2. In practical terms, I will have appraisals with all the leaders of the research groups at K2 and all scientists engaged in full positions. Each research group leader will not necessarily personally have an appraisal with every member of his/her group, but should make sure that the members of the group are offered an appraisal. The plan is that everybody at K2 should have been offered an appraisal during the autumn.
Per
University of Bergen has a new plan of action – Health, safety and environment at UiB – a good working environment for all.
You can find it here.
Forskningskonsulentene ved fakultetets 5 institutter har tatt initiativ til en karrieredag for fakultetets ph.d-kandidater 6. oktober. Arrangementet er støttet av fakultetet og visedekan for forskerutdanning Roland Jonsson vil åpne dagen
UiB welcome you to the Alumus-day, saturday September 10th 2016 at 11 AM.
The event is free for both UiB staff and past and current UiB students. Fell free to bring Your friends and Family.
More information can be found here.
Qu Y, Gharbi N, Yuan X, Olsen JR, Blicher P, Dalhus B, Brokstad KA, Lin B, Øyan AM, Zhang W, Kalland KH, Ke X. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer.
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9339-44. doi: 10.1073/pnas.1604520113. Epub 2016 Aug 1. PMID: 27482107
This publication was selected to be highlighted in the Editors’ Choice
section of Science Signaling, the weekly journal from the publisher of
Science magazine: http://stke.sciencemag.org/content/9/442/ec192
This publication also has been selected for a Feature editorial that will be published in the journal Cell Cycle.
CUHK is a very reputable research university in Hong Kong / China with excellence of research and infrastructure. A lot of UiB researchers collaborate with CUHK, both bilaterally and multilaterally through Wun. As Wun member university, the University of Bergen one of CUHK priority international partners and UiB researchers administered thereby the opportunity to apply for funding for research stays at CUHK through their Inbound Research Mobility Scheme.
This is an opportunity for UiB researchers to apply for funding for research at Chinese University of Hong Kong (CUHK) during the 1st half 2017
We hereby invite you to attend the local symposium in the memory of Helga B. Salvesen to be held 14th September 2016 in Store Auditorium at Haukeland University Hospital. The symposium is titled “Biomarkers in Female Cancer” and is a joint effort between CCBIO and the K2 department at UiB and Kvinneklinikken at Helse Bergen. The aim of the symposium is to honor Helgas memory by focusing on the state of the art within research on gynecologic cancer as well as younger researchers efforts within the field.
As you can see from the program (link below), we have secured international, national and local speakers. There will also be a combined lunch and poster session in the Aula of the Building for Basic Biological Research (BBB), where younger researchers can present their work. The symposium is open to all and free of charge, so please feel free to forward this invitation.
We would like to underline that all participants need to register through the below link within 8th September 2016. Please note that after pressing “Continue” and reviewing the registration you need to press “Register”. You are not registered before you have received the confirmation.
Questions: To CCBIOs Administrative Leader Geir Olav Løken on geir.loken@uib.no
We hope that Helgas memorial symposium will be an inspiring event to all participants!
On behalf of CCBIO and its partners at K2 and Kvinneklinikken,
Helga Bergljot Midtbø will defend her PhD thesis on Friday, September 9th, 2016
Trial lecture: Friday, September 9th, 2016 09:30
Topic: “The bearing of inflammation on cardiovascular disease. Present knowledge and future Challenges”
Place: Stort auditorium, Haukeland Universitetssykehus
Public defense: Friday, September 9th, 2016 11:15
Place: Stort auditorium, Haukeland Universitetssykehus
Title of dissertation: “Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors”
1st opponent: Associate professor Giuseppe Schillaci, Universitetet i Perugia, Italia
2nd opponent: Professor Karin Manhem, Universitetet i Gøteborg, Sverige
It is common to think that the end product of a research project are the publications that come out of the project. Many would add that the popular scientific dissemination of the project results is also part the end product: dissemination provides added value of the project results by demonstrating their utility to the society.
Innovation may also contribute to added value and increased society benefit. Commercialization of a research project is to move from possibility to reality: to offer new diagnostics and therapies to the society, not only lay the their foundation. Innovation is like research a creative process, but with a slightly different focus more geared towards market-oriented application. Both the Western Norway Regional Health Authority (Helse Vest) and the ERC funding institutions evaluate the innovation potential of a project in the funding application processes, and the Western Norway Regional Health Authority also awards an Innovation Prize.
The Department of Clinical Science (K2) wants to strengthen innovation at the Department by setting goals for innovation in the strategic plan, but also through an established partnership with Bergen Technology Transfer Office (BTO) where a counselor from BTO, Kine Gregersen, will be available in the K2 expedition in the 8th floor every 2. and 4th Tuesday of the month. We hope you find an opportunity to reach out to her. Conversely, she will actively try to find an opportunity to consult with someone in your research group. Please embrace such an initiative if you do not take action yourself, it can pay off!
Helge Ræder
The summer is ending and it’s time to get started with this autumn’s training plans. Employee instruction starts up again in Week 34, and the times will be the same as in the spring semester. See Safety portal for more information on training for employees.
Course in clinical studies including ICH-GCP (GCP901) is a very relevant course for PhD students doing clinical Research
At this course you will be given a thorough introduction to:
Dates:
Day 1: 26th of September (half day)
Day 2: 29th of September (whole day)
Day 3: 7th of October (half day)
Registration: at the Studentweb by 1st of September
If you have any questions regarding the course please feel free to contact:
Course content: Eyvind Rødahl – Eyvind.Rodahl@uib.no , Thomas Halvorsen- thomas.halvorsen@helse-bergen.no or Stefan Johansson – Stefan.Johansson@uib.no Administrative matters: Solveig Lund Witsø Solveig.Witso@uib.no
Cytostatikaboken i ny utgave kan bestilles fra Bjørg Algerøy (bjorg.algeroy@helse-vest.no) tlf 72070.
Boken vil koste kr. 450,-
Regarding our new Illumina HiSeq4000 next-generation sequencing system the Genomics Core Facility is happy announce a NGS application seminar Thursday September 8th.
Time: September 8th, 13.00 – 16.00.
Place: Meeting room 5.1/5.2, 5th floor Laboratory building.
Please see the invitation here for more information on the program and for registration to the seminar.
We wish to invite you all to the next K1/K2 Seminar in 2016. Tuesday August 30th!
Grant Brinkworth -PhD, associate professor, University of South Australia, Adelaide, Australia
Principal Research Scientist at CSIRO – Food and Nutrition, Adelaine, AUS
Long-term health and safety effects of Very Low Carbohydrate Diets for Type 2 Diabetes Management:
Current clinical practice guidelines for type 2 diabetes management advocate a diet low in fat and high in unrefined carbohydrates. However, this recommendation has been questioned following advancements in understanding that carbohydrate restriction and higher intakes of protein and unsaturated fat improve blood glucose control and cardiovascular disease risk.
This presentation will discuss the findings of a large, long-term, well-controlled, randomized controlled clinical study comparing the effects of either a traditional high-carbohydrate diet or a very-low-carbohydrate, high-unsaturated-fat diet while participating in a structured exercise program on multiple health outcomes, including glycemic control, cardiovascular disease risk, renal function, and mental wellbeing and performance.
Findings indicate that independent of any change in weight, the blood glucose profile improves substantially in the very-low-carbohydrate group. The diet is well tolerated and the need for medication is also reduced to a greater extent than the traditional high-carbohydrate dietary approach.
Time: Tuesday August 30th, 14:30 – 15:30
Pace: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Simon Dankel, Dep. Of Clinical Science, UiB
Pizza is served between 14:15 -14:30
Everyone is welcome.
In connection with the annual Scandinavian Conference in Cardiothoracic Surgery in Reykjavik August 17th -19th of this year, our PhD candidate cand.med. Terje Aass nominated and won the award “C. Walton Lillehei, Ph.D., M. D. Young Investigators Award “of $ 5,000 for his lecture:
Myocardial energy status and ultrastructure with polarizing and depolarizing cardioplegia arrest in a porcine model.
Terje Aass is chief physician at Thoracic Surgery Section, Department of Cardiology, Haukeland University Hospital, and is also working on a PhD project related to Cardiovascular Research Group at K2. The project is an animal experimental study of a new kardioplegiløsning used to stop the heart and protect myocardium by open heart surgery in which a user heart-lung machine.
Walton Lillehei, an American heart surgeon with Norwegian idea, termed internationally as the open hjertekirurgiens father.
Here you will find this weeks application deadlines:
2nd annual Bergen Stem Cell Consortium (BSCC) meeting will be held at Solstrand, September 5-6th 2016
Click here for the program
Marie Skłodowska-Curie actions:
https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions
Dead line: September 14th-16
ERC Starting grants: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/erc-2017-stg.html#c,topics=callIdentifier/t/ERC-2017-STG/1/1/1/default-group&callStatus/t/Forthcoming/1/1/0/default-group&callStatus/t/Open/1/1/0/default-group&callStatus/t/Closed/1/1/0/default-group&+identifier/desc
Dead line: October 18th-16. Those who need funding from 2018 must apply now
HELSEVEL- program calls for projects within the public sector, deadline October 12th.
Target group: researchers within the public health and care sector
Well belated summer! I hope everyone got to recharge their batteries and are now ready for the autumn. The editorial that was issued just before the summer dealt with K2’s new strategy document and it stated that we would use it actively in our efforts to enhance K2. The strategy document concerns us all and you can find it here if you need to freshen it up. The K2 management will have a particular focus on the following issues in the strategy document this fall: Recruitment, publication activity, use of MittUiB, Canvas and Inspera and financial reporting. We will come back to these issues in future editorials. When it comes to recruitment, the following should be noted: The K2 economy is now balanced, and in the next few years there are some natural age retirements. This opens opportunities for strategic recruitment.
Øystein Bruserud was the head of the Recruitment committee, who recommended that when recruiting after retirement we should check first that the teaching requirements within that particular field is covered. Then the vacant position should be advertised as broad as possible to ensure the best possible recruitment. I think these are good thoughts.
To be continued.
Per